Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paulo C Rodriguez

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
Cancer Immunology Research|March 3, 2021
Targeted Therapy Given after Anti-PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor ImmunityManali S Phadke, Zhihua Chen, Jiannong Li, et al.
Cancer Cell|October 10, 2025
Developing SEMA4A-directed CAR T cells to overcome low BCMA antigen density in multiple myelomaFrancesco Di Meo, Francesca Albano, Annamaria Cesarano, et al.
Ebiomedicine|March 6, 2022
Increased inflammatory low-density neutrophils in severe obesity and effect of bariatric surgery: Results from case-control and prospective cohort studiesMaria Dulfary Sanchez-Pino, William S Richardson, Jovanny Zabaleta, et al.
Cancer Research|April 11, 2022
Carbon Monoxide Activates PERK-Regulated Autophagy to Induce Immunometabolic Reprogramming and Boost Antitumor T-cell FunctionParamita Chakraborty, Rasesh Y Parikh, Seungho Choi, et al.
Cancers|July 14, 2023
Relationships among Inflammatory Biomarkers and Self-Reported Treatment-Related Symptoms in Patients Treated with Chemotherapy for Gynecologic Cancer: A Controlled ComparisonAasha I Hoogland, Brent J Small, Laura B Oswald, et al.
Blood|January 29, 2021
Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphomaMichael D Jain, Hua Zhao, Xuefeng Wang, et al.
Research Square|January 3, 2024
Transgelin 2 guards T cell lipid metabolic programming and anti-tumor functionSung-Min Hwang, Deepika Awasthi, Jieun Jeong, et al.
Cancer Research|December 24, 2021
IgA-Dominated Humoral Immune Responses Govern Patients' Outcome in Endometrial CancerGunjan Mandal, Subir Biswas, Carmen M Anadon, et al.
Immunity|November 1, 2023
Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm and immune-mediated control of epithelial cancersSubir Biswas, Gunjan Mandal, Carmen M Anadon, et al.
Cancer Cell|September 23, 2022
Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responsesJessica K Mandula, Shiun Chang, Eslam Mohamed, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
Cancer Immunology Research|March 3, 2021
Targeted Therapy Given after Anti-PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor ImmunityManali S Phadke, Zhihua Chen, Jiannong Li, et al.
Cancer Cell|October 10, 2025
Developing SEMA4A-directed CAR T cells to overcome low BCMA antigen density in multiple myelomaFrancesco Di Meo, Francesca Albano, Annamaria Cesarano, et al.
Ebiomedicine|March 6, 2022
Increased inflammatory low-density neutrophils in severe obesity and effect of bariatric surgery: Results from case-control and prospective cohort studiesMaria Dulfary Sanchez-Pino, William S Richardson, Jovanny Zabaleta, et al.
Cancer Research|April 11, 2022
Carbon Monoxide Activates PERK-Regulated Autophagy to Induce Immunometabolic Reprogramming and Boost Antitumor T-cell FunctionParamita Chakraborty, Rasesh Y Parikh, Seungho Choi, et al.
Cancers|July 14, 2023
Relationships among Inflammatory Biomarkers and Self-Reported Treatment-Related Symptoms in Patients Treated with Chemotherapy for Gynecologic Cancer: A Controlled ComparisonAasha I Hoogland, Brent J Small, Laura B Oswald, et al.
Blood|January 29, 2021
Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphomaMichael D Jain, Hua Zhao, Xuefeng Wang, et al.
Research Square|January 3, 2024
Transgelin 2 guards T cell lipid metabolic programming and anti-tumor functionSung-Min Hwang, Deepika Awasthi, Jieun Jeong, et al.
Cancer Research|December 24, 2021
IgA-Dominated Humoral Immune Responses Govern Patients' Outcome in Endometrial CancerGunjan Mandal, Subir Biswas, Carmen M Anadon, et al.
Immunity|November 1, 2023
Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm and immune-mediated control of epithelial cancersSubir Biswas, Gunjan Mandal, Carmen M Anadon, et al.
Cancer Cell|September 23, 2022
Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responsesJessica K Mandula, Shiun Chang, Eslam Mohamed, et al.
Pageof 12